MAXIMUM STRENGTHRanitidine Tablets USP, 150mg
Ranitidine by
Drug Labeling and Warnings
Ranitidine by is a Otc medication manufactured, distributed, or labeled by Vivimed Labs Limited, Strides Vivimed Pte. Ltd., Vivimed Life Sciences Private Limited. Drug facts, warnings, and ingredients follow.
Drug Details [pdf]
RANITIDINE 150 MG- ranitidine tablet, film coated
Vivimed Labs Limited
----------
MAXIMUM STRENGTH
Ranitidine Tablets USP, 150mg
Drug Facts
Active ingredient (in each tablet)
Ranitidine 150 mg (as ranitidine hydrochloride USP, 168 mg)
Uses
- relieves heartburn associated with acid indigestion and sour stomach
- prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages
Do not use
- if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
- with other acid reducers
Ask a doctor before use if you have
- had heartburn over 3 months. This may be a sign of a more serious condition.
- heartburn with lightheadedness, sweating or dizziness
- chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
- frequent chest pain
- frequent wheezing, particularly with heartburn
- unexplained weight loss
- nausea or vomiting
- stomach pain.
- kidney disease
Ask a doctor or pharmacist before use if you are taking a prescription drug. Acid reducers may interact with certain prescription drugs.
Stop use and ask a doctor if
- your heartburn continues or worsens
- you need to take this product for more than 14 days.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
- adults and children 12 years and over:
to relieve symptoms, swallow 1 tablet with a glass of water
to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
can be used up to twice daily (do not take more than 2 tablets in 24 hours)
do not chew tablet
- children under 12 years: ask a doctor
Other information
- do not use if printed foil under bottle cap is open is open or torn (bottles)
- do not use if individual blister unit is open or torn (blisters)
- store at 20° to 25°C (68° to 77°F)
- avoid excessive heat or humidity
- this product is sodium and sugar free
Inactive ingredients
colloidal silicon dioxide, ferric oxide red, glyceryl monostearate, magnesium stearate, microcrystalline cellulose, polyvinyl alcohol, sodium lauryl sulphate, talc, and titanium dioxide
Questions?
call Vivimed Labs USA at 732-398-0008
Tips for managing heartburn
Read the directions and warning before use. Keep the carton. It contains important information including tips for managing heartburn
Manufactured in INDIA for :
Vivimed Labs USA,
1100 Cornwall Road, Suite 160,
Monmouth Junction, NJ 08852, USA.
Rev. 11/2019
M.L. No.: TN00002326
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
MAXIMUM STRENGTH
Ranitidine Tablets, USP
150 mg
ACID REDUCER
PREVENTS & RELIEVES HEARTBURN associated with acid indigestion and sour stomach
30 tablets
Vivimed
Read the directions and warnings before use. Keep the carton. It contains important information including tips for managing heartburn.
MAXIMUM STRENGTH
Ranitidine Tablets, USP
150 mg
ACID REDUCER
PREVENTS & RELIEVES HEARTBURN associated with acid indigestion and sour stomach
500 tablets
Vivimed
Read the directions and warnings before use. Keep the carton. It contains important information including tips for managing heartburn.
MAXIMUM STRENGTH
Ranitidine Tablets, USP
150 mg
ACID REDUCER
PREVENTS & RELIEVES HEARTBURN associated with acid indigestion and sour stomach
28 film-coated tablets (4 x 7's Blister pack)
Vivimed
Read the directions and warnings before use. Keep the carton. It contains important information including tips for managing heartburn.
| RANITIDINE
150 MG
ranitidine tablet, film coated |
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||
| Labeler - Vivimed Labs Limited (650210664) |
| Registrant - Strides Pharma Global Pte. Ltd. (659220961) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
|---|---|---|---|
| Vivimed Life Sciences Private Limited | 860477684 | ANALYSIS(62980-512) , MANUFACTURE(62980-512) | |